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Abstract 
Background: Oral mucositis is among the most important adverse effects of chemotherapy and bone marrow 
transplantation and prevention from this side effect is important to improve the situations in patients. Hence, in 
this study the main aim was to determine the effects of low-level laser therapy on mucositis in patients under 
chemotherapy and bone marrow transplantation. 
Materials and Methods: In this randomized controlled clinical trial, 60 consecutive patients under 
chemotherapy and bone marrow transplantation in a training hospital in 2018 were enrolled and randomly 
assigned to receive either low-level laser therapy (630 and 780 nm) or off-laser. Finally, the frequency rate and 
severity of mucositis (grades 0 to 4 according to WHO severity index) were determined and compared across 
the groups. 
Results: Mucositis was present in 30% and 56.7% in laser and control groups, respectively with statistically 
significant difference (p=0.037). The severity of mucositis was same across the laser and control groups 
(p=0.785). 
Conclusion: Low-level laser therapy is an effective modality for preventing from mucositis in patients treated 
by chemotherapy and bone marrow transplantation. Accordingly, utilization of this safe and effective 
therapeutic method is recommended. 
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Introduction 
Oral mucositis is a common problem in cancer 
patients under treatment with either radiotherapy or 
chemotherapy especially with high-dose or 
combination treatment with frequency rate from 20 
to 80 percent1-3. Oral washing with normal saline, 
sodium-carbonate, calcium-phosphate, and 
chlorhexidine are conventional treatments1-4. 
Regarding low efficacy of these routine therapeutic 
modalities, currently laser treatment is being 
considered5-8. It would affect the mitochondrial 
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respiratory chain leading to increased production of 
ATP and reactive oxygen species that result in 
fibroblast proliferation and collagen synthesis 
stimulating inflammatory responses and tissue 
healing6-10. Both conventional and infrared lasers are 
beneficial8-10. 
Since oral mucositis is a general disabling 
condition11usually after short interval from therapy 
untill two weeks later in many patients12, 13 with 
different severities and clinical spectrum14,15 and it is 
accompanyed with increased infection 
susceptibility11, 12 and oral pain13 and may result in  
hospital admission15, in this study the aim was to 
determine effects of low level laser therapy on 
mucositis in patients under chemotherapy and bone 
marrow transplantation. 
Methods 
In this randomized controlled clinical trial, 60 
consecutive patients under chemotherapy and bone 
marrow transplantation in a training hospital in 2018 
were enrolled. The inclusion criteria were age older 
than 18 years and possibility for being followed-up. 
Exclusion criteria were autoimmune diseases, severe 
major adverse effects, receiving other therapeutics, 
inability to respect the laser care guidelines, and over 
three times pause in the therapeutic course. Local 
ethical committee with ethical code of 
IR.SBMU.MSP.REC.1396.580 approved the study. 
Patients were randomly assigned to receive either 
low-level laser therapy (630 and 780 nm) or off-laser 
beside standard treatments. Treatment was three 
times weekly since first chemotherapy day untill 
second transplantation day with energy density of 4 
j/cm² for two minutes. The energy and density were 
same for all cases in intervention group. Glasses 
covered the eyes during laser therapy for safety 
issues. Finally, the frequency rate and severity of 
mucositis (grades 0 to 4 according to WHO severity 
index) was determined and compared across the 
groups by daily physical examinations. In addition, 
eating problems and weight reductions were recorded 
for all patients. The body mass index was measured 
weekly. 
Data analysis among 60 patients including 30 
subjects in intervention group and 30 cases in 
intervention group was done by SPSS version 13.0 
software and the utilized tests were Independent-
Sample-T, Fisher, and Chi-Square and the P values 
under 0.05 were considered statistically significant. 
Results 
The mean (standard deviation) age was 39.03 (13.45) 
and 38.60 (11.62) years laser and control groups, 
respectively (p=0.894). There were 15 (50%) and 16 
(53.3%) male subjects in laser and control groups, 
respectively (p=0.796). As shown in Figure-1, the 
transplantation type was allogen in 46.7% and 33.3% 
in laser and control groups, respectively (p=0.292). 
Number of sessions was 1, 2, 3, and 4 in 13.3%, 40%, 
36.7%, and 10%, respectively.  
Mucositis was present in 30% and 56.7% in laser and 
control groups, respectively with statistically 
significant difference (p=0.037). As shown in Figure-2 
the severity of mucositis was same across the laser and 
control groups (p=0.785). Age, transplantation type, 
and number of sessions were not related to mucositis 
(p>0.05). However, the mucositis was more common 
among female subjects in laser group (53.3% versus 
6.7%) with significant difference (p=0.014). 
Discussion 
Mucositis is an important complication after bone 
marrow transplantation and chemotherapy and we 
assessed the efficacy of laser to improve this problem 
in patients. In current study, the efficacy of treatment 
for prevention of mucositis in laser group was 
approximately two-fold higher than laser-off group but 
the severity of mucisitis was not significantly altered. 
Cauwelset al3 reported significant efficacy for laser 
wavelength of 830 nm in pediatric samples. They also 
reported decreased pain in patients. Regarding some 
information biases, pain was not assessed in our study. 
Guatam and colleagues4 similarly reported fewer 
incidences of mucositis in intervention versus control 
group. Another study by them5 also established the 
efficacy of laser in reduction of mucositis. Aoton-
Leite et al6 demonstrated decreased severity of 
mucositis by laser-therapy. However, in our study, 
only the frequency rate of mucositis was decreased by 
laser therapy and the severity was alike across the 
groups. 
Silva et al7 also showed that laser therapy led to 
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decreased severity of mucositis. However, due to 
some technical and design differences the severity 
was not significantly differed in our study. The study 
by Emamiet al16 showed that mucositis was present 
in 31% and 41% in laser and placebo groups that is 
congruent with our results but unlike our study, the 
difference was not statistically significant. 
Gholizadeh et al17 reported in a review article that 
low-potency laser would result in improved mucosal 
healing and increased collagen synthesis that result in 
reduced inflammation and lower rate of mucositis. 
This article shows the background mechanism of our 
obtained results. In their review article, Jadaud et al18 
reported high efficacy and safety of low-potency laser 
to prevent mucositis. 
Oberoi et al19 reported reduction in mucositis 
frequency and severity in 37 and 34 percent, 
respectively. However, in our study, only the 
frequency rate of mucositis was decreased and the 
severity of it showed no significant changes. Silva et 
 
 




Figure 2. Severity of mucositis across the groups. 
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al20 also reported reduced intensity of mucositis by 
low-potency laser. The cause of difference between 
the studies is different methods and types of 
utilization of laser across them. In a systematic 
review, He et al21 showed 50 percent reduction in 
mucositis frequency that was also seen in our study 
however they also reported reduction in severity by 
30 percent that was not established in current study. 
Conclusion 
Low-level laser therapy is effective for prevention of 
mucositis in patients treated by chemotherapy and 
bone marrow transplantation. Accordingly, 
utilization of this safe and effective therapeutic 
method is recommended. However further studies 
with larger sample size and comparisons with other 
possible methods are required for better decision-
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